Picture of SpringWorks Therapeutics logo

SWTX — SpringWorks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Brief: Merck Says Transaction Approved, Expected To Close In Second Half 2025

April 28 (Reuters) - Merck KGaA MRCG.DE:

MERCK KGAA, DARMSTADT, GERMANY TO ACQUIRE SPRINGWORKS THERAPEUTICS TO ACCELERATE SUSTAINABLE GROWTH OF HEALTHCARE BUSINESS

MERCK KGAA - TRANSACTION APPROVED, EXPECTED TO CLOSE IN SECOND HALF 2025

Source text: ID:nGNX5S1mxJ

Further company coverage: MRCG.DE

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on SpringWorks Therapeutics

See all news